Tanfield said the investment is worth GBP19.1 million. In October 2019, Tanfield said it had received a summons and complaint in Nevada, US that alleged that Xtreme can buy Tanfield's interest in ...

Arecor Chief Executive Sarah Howell said: "We are pleased to partner with Skye Bioscience to support the development of a novel, enhanced formulation of nimacimab, a promising first-in-class candidate ...